These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 15934081

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
    Sieper J, Klopsch T, Richter M, Kapelle A, Rudwaleit M, Schwank S, Regourd E, May M.
    Ann Rheum Dis; 2008 Mar; 67(3):323-9. PubMed ID: 17616556
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Study protocol: COmparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of StrUctural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) - an open-label randomized controlled multicenter trial.
    Proft F, Muche B, Listing J, Rios-Rodriguez V, Sieper J, Poddubnyy D.
    BMJ Open; 2017 Jun 10; 7(6):e014591. PubMed ID: 28601821
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.
    Park JW, Kim MJ, Lee JS, Ha YJ, Park JK, Kang EH, Lee YJ, Song YW, Lee EY.
    Arthritis Rheumatol; 2019 Jan 10; 71(1):82-90. PubMed ID: 29984487
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study.
    Kristensen LE, Jakobsen AK, Askling J, Nilsson F, Jacobsson LT.
    Arthritis Care Res (Hoboken); 2015 Aug 10; 67(8):1137-49. PubMed ID: 25623277
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.
    Barkhuizen A, Steinfeld S, Robbins J, West C, Coombs J, Zwillich S.
    J Rheumatol; 2006 Sep 10; 33(9):1805-12. PubMed ID: 16960941
    [Abstract] [Full Text] [Related]

  • 13. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.
    van der Heijde D, Landewé R, Einstein S, Ory P, Vosse D, Ni L, Lin SL, Tsuji W, Davis JC.
    Arthritis Rheum; 2008 May 10; 58(5):1324-31. PubMed ID: 18438853
    [Abstract] [Full Text] [Related]

  • 14. The safety of celecoxib in ankylosing spondylitis treatment.
    Poddubnyy DA, Song IH, Sieper J.
    Expert Opin Drug Saf; 2008 Jul 10; 7(4):401-9. PubMed ID: 18613804
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G, SUCCESS-I Investigators.
    Am J Med; 2006 Mar 10; 119(3):255-66. PubMed ID: 16490472
    [Abstract] [Full Text] [Related]

  • 16. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.
    van der Heijde D, Landewé R, Baraliakos X, Houben H, van Tubergen A, Williamson P, Xu W, Baker D, Goldstein N, Braun J, Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group.
    Arthritis Rheum; 2008 Oct 10; 58(10):3063-70. PubMed ID: 18821688
    [Abstract] [Full Text] [Related]

  • 17. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study.
    Emery P, Koncz T, Pan S, Lowry S.
    Clin Ther; 2008 Jan 10; 30(1):70-83. PubMed ID: 18343244
    [Abstract] [Full Text] [Related]

  • 18. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
    Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, Hubbard RC, Isakson PC, Verburg KM, Geis GS.
    Mayo Clin Proc; 1999 Nov 10; 74(11):1095-105. PubMed ID: 10560596
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.
    Rother M, Lavins BJ, Kneer W, Lehnhardt K, Seidel EJ, Mazgareanu S.
    Ann Rheum Dis; 2007 Sep 10; 66(9):1178-83. PubMed ID: 17363401
    [Abstract] [Full Text] [Related]

  • 20. Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo-controlled, double-blind 2-week study.
    Sakamoto C, Kawai T, Nakamura S, Sugioka T, Tabira J.
    Aliment Pharmacol Ther; 2013 Feb 10; 37(3):346-54. PubMed ID: 23216412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.